NCT04471779View on ClinicalTrials.gov

Information About Alzheimer's Disease for Latinos in New York City

NAActive, not recruitingINTERVENTIONAL
Enrollment

374

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Alzheimer Disease
Interventions
OTHER

Disclosure of APOE genotype

Information about risk of Alzheimer's disease will be given to participants based on their APOE genotypes, in addition to Latino ethnicity and family history.

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Columbia University

OTHER